Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same ...

Revenue was down 5.9% from last year to $16.654, after increasing 10% the previous quarter. These results were better than ...

Pfizer (PFE) exceeded Street forecasts with its Q3 2025 results on Tuesday, thanks mainly to sales from its COVID vaccine ...

The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical ...

New and changing FDA and CDC guidance on COVID-19 vaccine eligibility has left many confused. Here's what to know about getting the shot this fall.

Stratus and Nimbus have similar symptoms to previous variants including a fever, cough and runny nose, but the Nimbus variant has one distinct symptom: a ‘razor blade’ sore throat. These two variants ...

A federal court compensates people who say they were injured by vaccines. Here is why the COVID vaccines are not currently part of it.

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

The CDC officially adopted recommendations made​ by the agency's vaccine advisory committee, whose members were hand-picked by Secretary Kennedy.

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

RNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.

Martha Evans has been getting a yearly flu shot for as long as she can remember and the COVID-19 vaccinations, including regular boosters, since the end of 2020 when the vaccine first became available ...